FDA Adverse Event
Other
Summary report: N
ESSURE
MDR report key: 2851108
·
Received November 16, 2012
Report
- Report Number
- 2951250-2012-00049
- Event Type
- Other
- Date Received
- November 16, 2012
- Date of Event
- October 18, 2012
- Report Date
- January 19, 2017
- Manufacturer
- BAYER PHARMA AG
- Product Code
- HHS
- PMA / PMN Number
- P020014
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- NOT APPLICABLE
Narratives
Additional Manufacturer Narrative · 1
(B)(4).
Description of Event or Problem · 1
PATIENT REPORTED TO MANUFACTURER THAT FOLLOWING HSG TEST, (B)(6) PHYSICIAN TOLD HER THAT SHE WAS NOW STERILE AND COULD RELY ON DEVICES. SHE SUBSEQUENTLY HAD AN ECTOPIC PREGNANCY FOLLOWED BY AN INTRAUTERINE PREGNANCY. DATE OF AND TREATMENT FOR ECTOPIC PREGNANCY ARE UNKNOWN. SECOND PREGNANCY OCCURED APPROXIMATELY IN (B)(6) 2011. (B)(6). MANUFACTURER HAS MADE NUMEROUS ATTEMPTS TO CONTACT PATIENT, BUT HAS BEEN UNABLE TO OBTAIN FURTHER INFORMATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ESSURE | INSERT, TUBAL OCCLUSION | HHS | BAYER PHARMA AG | ESS305 | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 31 YR | Required Intervention |